CovaIX AG and BioAnalyte are codeveloping software for discovering how proteins interact in large complexes.
Prosolia received an NIH Small Business Technology Transfer grant to develop with Indiana University an atmospheric pressure glow discharge for direct analysis of samples under ambient conditions.
Agilent announced a Cooperative Research and Development Agreement with the EPA’s National Exposure Research Laboratory to use TOF-MS to detect and identify perfluorinated compounds in the environment.
Agilent partnered with the University of Michigan’s Center for Translational Pathology through a grant of instruments and funding.
Bio-Rad Laboratories entered into an agreement to develop and market its SELDI technology in combination with Bruker’s MALDI-TOF/TOF systems for high-throughput protein profiling and identification, particularly for intact peptides and proteins under 30 kDa.
Waters entered into a purchase/supply agreement with Peak Scientific Instruments for nitrogen gas generators, spare parts and services for its LC/MS systems.
Waters is collaborating with England’s University of Warwick to develop biomedical MS technologies for research and opened a center of excellence at the school.
Under a two-and-a-half year, $1.3 billion contract with the National Cancer Institute, Intrinsic Bioprobes will develop multiplex MS immunoassays for the detection of low-abundance cancer-related proteins and peptides from bodily fluids.
Agilent released the Agilent G6855 MassHunter Forensic and Toxicology Database for identification of more than 7,500 compounds based on LC/MS data.
In April, Applied Biosystems/MDS Analytical Technologies launched the AB SCIEX TOF/TOF 5800 System for 10 times faster data acquisition and low-attomole sensitivity. It features a 1 kHz OptiBeam on-axis laser and ProteinPilot 3.0 software.
Bruker Daltonics introduced the ultrafleXtreme MALDI-TOF/TOF MS with a 1 kHz smartbeam-II laser, broadband mass resolving power up to 40,000, and ProteinScape 2.0 for 1 ppm mass accuracy.
Sales/Orders of Note
South Korea awarded ICx Technologies a multiyear contract worth up to $40 million to develop a chemical and biological MS for use in military reconnaissance vehicles. ICx will introduce the product in the South Korean military market in partnership with Hankuk Communication.
The US Department of Defense Joint Program Executive Office for Chemical and Biological Defense awarded Hamilton Sundstrand a nearly $40 million contract to provide up to 156 Chemical Biological MS II devices.